Remove Analysis Remove Drug Development Remove Life Science Remove Telehealth
article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

Given the improvements in costs, trial sponsors can now take advantage of these exchanges at scale and leverage the data for both pre-screening and health economic analysis. As DCTs and virtual site acceptance accelerates, a knock-on effect will be that more of these trials will include HEOR analysis.

article thumbnail

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

Companies with niche technologies or expertise: Startups with unique solutions in specific areas like AI-powered diagnostics, remote patient monitoring, or telehealth platforms. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today!

article thumbnail

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the life sciences and healthcare sector. However, they are vital to the drug development and approval process and critical in enabling access to innovative medicines.